(Q53185117)

12 May 2018

title

Altered angiogenic balance in keloids: a key to therapeutic intervention. (English)

1 reference

12 May 2018

author name string

Nirupa Shyam Mogili

1

1 reference

12 May 2018

Venkat Raghavan Krishnaswamy

2

1 reference

12 May 2018

Meenakshi Jayaraman

3

1 reference

12 May 2018

Rama Rajaram

4

1 reference

12 May 2018

Alamelu Venkatraman

5

1 reference

12 May 2018

Purna Sai Korrapati

6

1 reference

12 May 2018

publication date

4 November 2011

1 reference

12 May 2018

published in

Translational Research

1 reference

12 May 2018

volume

159

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

182-189

1 reference

12 May 2018

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Endostatin: the logic of antiangiogenic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

The keloid phenomenon: progress toward a solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Hypoxia-induced HIF-1 alpha accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: involvement of ERK1/2 and PI-3K/Akt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Human skin keloid fibroblasts display bioenergetics of cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Molecular dissection of abnormal wound healing processes resulting in keloid disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Keloid pathogenesis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Hypoxia upregulates VEGF production in keloid fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Serum endostatin levels are elevated in patients with soft tissue sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Clinical significance of serum vascular endothelial growth factor, endostatin, and leptin levels in children with lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

The multiple functions of collagen XVIII in development and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Gelatinase activity in keloids and hypertrophic scars

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Identification of unique gene expression patterns within different lesional sites of keloids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Endostatin binds to the catalytic domain of matrix metalloproteinase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Endostatin's antiangiogenic signaling network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Endostatin is a potential inhibitor of Wnt signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.10.002

10.1016/J.TRSL.2011.10.002

7 January 2021

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018